Does TRICARE Cover Viagra (Sildenafil)? Coverage, Prior Auth, and Appeals Explained

Does TRICARE Cover Viagra or Sildenafil?

TRICARE covers generic sildenafil for erectile dysfunction with prior authorization, but brand-name Viagra is excluded under federal statute as a "lifestyle drug." The distinction matters because sildenafil and Viagra contain the identical active molecule, only the price and the brand name differ. Beneficiaries who receive prior authorization for sildenafil pay as little as $0 at a military treatment facility pharmacy or roughly $16 for a 90-day supply through TRICARE Pharmacy Home Delivery (Express Scripts).

The legal basis for the brand exclusion is 10 U.S.C. § 1075, which bars TRICARE reimbursement for drugs that promote sexual or cosmetic function when prescribed solely for that purpose [1]. The FDA approved sildenafil (Viagra) in March 1998 specifically for erectile dysfunction following the landmark Goldstein et al. trial published in the New England Journal of Medicine [2]. That trial (N=532) showed sildenafil 25 to 100 mg produced significantly improved erections versus placebo (P<0.001) across 12 weeks, establishing the evidentiary base regulators relied upon. Because the drug's primary indication is sexual function, it falls squarely within TRICARE's lifestyle-drug exclusion when prescribed for ED.

Generic sildenafil entered the U.S. market in December 2017, and TRICARE added it to the formulary shortly thereafter. The out-of-pocket difference is steep: brand Viagra carries a cash-pay list price near $700 per month for 30 tablets of 100 mg, while generic sildenafil averages around $50 per month at retail and far less through the TRICARE mail-order benefit [3].

What Is the TRICARE Formulary Tier for Sildenafil?

Generic sildenafil sits on Tier 2 (preferred generic) of the TRICARE Uniform Formulary. Tier placement determines copay, dispensing location, and whether prior authorization is required. Tier 2 drugs are available at military treatment facility pharmacies at no charge once a prior authorization is on file, at TRICARE Pharmacy Home Delivery for a reduced copay, and at retail network pharmacies for a higher but still modest copay.

The TRICARE Uniform Formulary is managed by the Defense Health Agency (DHA) and updated quarterly by the Pharmacy and Therapeutics (P&T) Committee [4]. Sildenafil's Tier 2 status has remained stable since the generic became widely available, reflecting the P&T Committee's assessment of cost-effectiveness and clinical evidence. Brand Viagra, by contrast, is placed in the excluded category rather than any cost-sharing tier, which means no amount of copay will purchase it through the TRICARE benefit.

Beneficiaries enrolled in TRICARE Prime, TRICARE Select, TRICARE for Life, and TRICARE Young Adult all operate under the same Uniform Formulary. The specific copay amounts differ slightly by plan type, but the formulary tier and prior authorization requirement do not change across plans [5].

Prior Authorization Criteria for Sildenafil Under TRICARE

Prior authorization for sildenafil requires a documented ED diagnosis, an appropriate prescriber type, and confirmation that the indication is not a lifestyle or off-label use excluded by statute. The prescribing clinician must submit a PA request to Express Scripts (the TRICARE pharmacy contractor) that includes the ICD-10 code N52.x (male erectile dysfunction), the intended dose and supply, and an attestation that the patient has a clinically confirmed organic or mixed-etiology ED diagnosis.

The Defense Health Agency's Pharmacy Benefits Management (PBM) clinical criteria additionally look for [6]:

• Patient age of 18 or older
• Confirmed diagnosis of erectile dysfunction (not a purely recreational or lifestyle request)
• Absence of contraindicated co-medications, particularly nitrates (e.g., nitroglycerin, isosorbide mononitrate), which carry a black-box warning for combined use with PDE5 inhibitors due to severe hypotension risk [7]
• Documentation that the prescriber has evaluated underlying cardiovascular risk, as the Princeton III Consensus recommendations advise risk stratification before any PDE5 inhibitor is started [8]

The PA is typically valid for 12 months and covers up to 8 tablets per 30-day period, a quantity limit aligned with the FDA-approved prescribing information for sildenafil [7]. Some TRICARE regions apply an initial 6-month authorization with renewal at 12 months thereafter.

Processing time for an electronic PA through Express Scripts is usually 24, 72 business hours for a standard review and up to 72 hours for a non-urgent request. Urgent requests, where a delay would cause significant clinical harm, must be processed within 24 hours per TRICARE policy [6].

Does TRICARE Require Step Therapy Before Approving Sildenafil?

Step therapy for sildenafil under TRICARE is not universally required, but certain regional contractors and plan types have historically requested documentation of lifestyle-modification counseling before approving the drug. This is a softer requirement than the rigid step-through-cheaper-agent protocols seen with some other drug classes.

The evidence base for lifestyle modification in ED is meaningful: a randomized controlled trial published in the Journal of Sexual Medicine (N=110) found that a 2-year exercise and weight-loss intervention improved IIEF-5 scores by 4.7 points on average, with 29% of participants achieving remission of ED without pharmacotherapy [9]. TRICARE's P&T Committee has cited this kind of data to justify asking prescribers to document whether behavioral counseling was offered or attempted.

In practice, most PA submissions that include a detailed clinical note referencing cardiovascular risk factors, diabetes status (type 2 diabetes affects erectile function in up to 52% of male patients) [10], or neurogenic ED etiology are approved without a formal step-therapy requirement. The step-therapy pathway becomes more prominent when a request lacks clinical detail or when the prescriber submits a minimal attestation without supporting chart documentation.

Providers should include the patient's most recent HbA1c (if diabetic), lipid panel, and blood pressure readings in the PA package. This level of detail reduces back-and-forth with the contractor and accelerates approval.

How to Submit a TRICARE Prior Authorization for Sildenafil

The submission process runs through Express Scripts, TRICARE's pharmacy benefits manager. Prescribers have three channels [6]:

1. Electronic submission via the CoverMyMeds portal (integrated with most major EHR systems)
2. Phone submission to Express Scripts at 1-877-363-1303
3. Fax submission using the TRICARE PA form to 1-877-895-1900

The PA form requires the prescriber's NPI, the patient's TRICARE sponsor ID, the NDC or drug name and strength, the diagnosis code, and the clinical attestation narrative. Incomplete forms are the most common cause of initial PA denial, accounting for an estimated 30 to 40% of first-contact rejections across pharmacy benefit managers nationally [11].

Patients can check PA status through the Express Scripts beneficiary portal at express-scripts.com or by calling the TRICARE Pharmacy Help Desk at 1-877-363-1303. Once approved, the PA is linked to the patient's TRICARE benefits and can be used at any network retail pharmacy, the MTF pharmacy, or TRICARE Home Delivery.

How to Appeal a TRICARE Denial of Sildenafil

A denial can be overturned. TRICARE's appeals process has three levels, and published data from the DHA show that beneficiary-initiated appeals succeed at meaningful rates when submitted with complete supporting documentation [12].

Level 1: Informal Review Submit a written request for reconsideration to Express Scripts within 90 days of the denial notice. Include the original denial explanation, an updated PA package with additional clinical documentation, and a letter from the prescriber explaining why sildenafil is medically necessary for this specific patient. Common grounds for a successful Level 1 appeal include documented cardiovascular comorbidities, neurogenic etiology, or evidence of prior successful response to sildenafil.

Level 2: Formal TRICARE Appeal If the Level 1 reconsideration is denied, submit a formal appeal to the TRICARE regional contractor within 90 days of the Level 1 decision. The regional contractor must issue a written decision within 60 days [12]. This level allows for submission of peer-reviewed clinical literature. Relevant documents include the Goldstein et al. NEJM trial [2] and the 2018 American Urological Association (AUA) guideline on erectile dysfunction [13].

Level 3: Independent Review The final administrative remedy is an independent review by the TRICARE Independent Review Entity. This level is reserved for cases involving significant clinical disagreement and requires exhaustion of Levels 1 and 2 first. Cases involving documented cardiovascular necessity or post-surgical ED (e.g., following radical prostatectomy) have the strongest track record at this level.

The appeal letter should reference 32 C.F.R. Part 199, the federal regulation governing TRICARE benefits, and should ask specifically whether the denial was based on the lifestyle-drug exclusion or on a clinical-criteria failure. The answer determines which additional evidence to submit.

Sildenafil for Non-ED Indications: Does Coverage Change?

Yes. Sildenafil is also FDA-approved under the brand name Revatio for pulmonary arterial hypertension (PAH) at doses of 20 mg three times daily [7]. When prescribed for PAH, the lifestyle-drug exclusion does not apply, and TRICARE covers sildenafil for this indication without the lifestyle-related restriction. The same is true for sildenafil prescribed off-label for Raynaud's phenomenon secondary to systemic sclerosis, although off-label use requires a more detailed medical necessity letter.

The ICD-10 code on the prescription and PA request determines which coverage pathway applies. A prescription carrying I27.0 (primary pulmonary hypertension) or I27.21 (secondary pulmonary arterial hypertension) routes to the PAH coverage pathway. A prescription carrying N52.x routes to the ED pathway with its lifestyle-drug exclusion for brand Viagra and PA requirement for generic sildenafil.

Prescribers should double-check the diagnosis code on every sildenafil prescription submitted to TRICARE. A coding error, particularly using an ED code for a PAH patient, can trigger a denial and delay treatment by several weeks [14].

Can TRICARE Beneficiaries Use a Manufacturer Savings Card for Viagra?

No. Federal anti-kickback statutes and 42 U.S.C. § 1320a-7b(b) prohibit using manufacturer copay assistance cards when the patient is covered by any federal health program, including TRICARE, Medicare, and Medicaid [15]. Using a Pfizer savings card for Viagra while billing TRICARE would constitute a federal violation, exposing both the patient and the dispensing pharmacy to civil monetary penalties.

This is a firm prohibition. The alternative for TRICARE beneficiaries seeking cost reduction is the generic substitution pathway: generic sildenafil from TRICARE Home Delivery runs approximately $16 for a 90-day supply at the Tier 2 copay rate, compared to approximately $700 per month for brand Viagra at list price. The savings are substantial without any legal risk.

Some beneficiaries have asked whether using a GoodRx coupon at a non-TRICARE pharmacy is permissible. Paying entirely out of pocket at a cash-pay pharmacy without billing TRICARE is legally allowed, but the beneficiary forfeits the TRICARE benefit for that fill. GoodRx pricing for generic sildenafil 100 mg (10 tablets) ranges from $15 to $30 at major chains.

TRICARE Coverage for Sildenafil in Special Populations

Active-Duty Service Members Active-duty personnel receive care primarily through MTF pharmacies. When sildenafil is prescribed by an MTF provider with a prior authorization on file, the copay is $0. Active-duty members with combat-related sexual dysfunction, including post-traumatic stress disorder-associated ED, spinal cord injury, or post-prostatectomy, are particularly strong candidates for PA approval and should document these etiologies explicitly [16].

TRICARE for Life (TFL) Beneficiaries TFL beneficiaries are Medicare-primary. Medicare Part D does not cover ED medications as a general rule, meaning TRICARE for Life acts as a secondary payer behind Medicare. Because Medicare denies the claim first, TFL's secondary payment obligations are limited. TFL beneficiaries seeking sildenafil for ED may need to work directly with the MTF pharmacy or TRICARE Home Delivery rather than routing through a retail Medicare Part D plan [5].

Dependents Sildenafil for ED is prescribed to adult male beneficiaries. Dependents aged 18 and older enrolled in TRICARE Young Adult (TYA) are subject to the same formulary and PA requirements as other beneficiaries, with the same copay structure.

Sildenafil Dosing and Clinical Context

Sildenafil for ED is available in 25 mg, 50 mg, and 100 mg tablets. The standard starting dose is 50 mg taken approximately 60 minutes before sexual activity, with dose titration to 100 mg or down to 25 mg based on response and tolerability [7]. The drug should not be taken more than once per day.

The FDA prescribing information carries a contraindication with organic nitrates due to the risk of severe hypotension. A 1999 post-marketing analysis published in JAMA identified 522 deaths among Viagra users in the first year after approval, prompting additional cardiovascular labeling, though causality was confounded by the high prevalence of underlying cardiac disease in this population [17]. Subsequent prospective trials, including the multicenter study by Mittleman et al. (N=1,473), found no significant increase in myocardial infarction risk when sildenafil was used in patients cleared by cardiovascular risk stratification [18].

Patients with creatinine clearance <30 mL/min or significant hepatic impairment should start at 25 mg. Concomitant use of alpha-blockers (e.g., tamsulosin, terazosin) requires a 4-hour separation between doses to minimize orthostatic hypotension risk [7].

What to Do If TRICARE Keeps Denying Sildenafil

Repeated denials after multiple appeals are uncommon for patients with documented organic ED, but they do occur when the clinical record is sparse. The most effective corrective steps are:

First, request the specific denial reason in writing. TRICARE is required to provide one under 32 C.F.R. § 199.10 [12]. Second, have the prescribing physician submit a detailed medical necessity letter (at least one page) referencing the patient's specific diagnosis, etiology, relevant comorbidities, and why sildenafil is the appropriate agent. Third, if the denial cites the lifestyle-drug exclusion, explore whether the patient has a secondary diagnosis, such as neurogenic ED following spinal surgery, that removes the prescription from the lifestyle-drug category entirely.

Patients who exhaust all administrative appeals without success retain the right to seek judicial review under 5 U.S.C. § 706, though this step is rarely necessary for formulary decisions involving a covered generic [12].

For beneficiaries who cannot obtain TRICARE coverage, the cash-pay generic option through TRICARE Home Delivery at approximately $16 per 90-day supply remains the lowest-cost legal alternative.